These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29284494)

  • 1. Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging.
    Nguyen KL; Park EA; Yoshida T; Hu P; Finn JP
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):106. PubMed ID: 29284494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion.
    Shahrouki P; Moriarty JM; Khan SN; Bista B; Kee ST; DeRubertis BG; Yoshida T; Nguyen KL; Finn JP
    J Cardiovasc Magn Reson; 2019 Mar; 21(1):17. PubMed ID: 30853026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4D MUSIC CMR: value-based imaging of neonates and infants with congenital heart disease.
    Nguyen KL; Han F; Zhou Z; Brunengraber DZ; Ayad I; Levi DS; Satou GM; Reemtsen BL; Hu P; Finn JP
    J Cardiovasc Magn Reson; 2017 Apr; 19(1):40. PubMed ID: 28366171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children.
    Ruangwattanapaisarn N; Hsiao A; Vasanawala SS
    Pediatr Radiol; 2015 Jun; 45(6):831-9. PubMed ID: 25427433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4D flow image quality with blood pool contrast: a comparison of gadofosveset trisodium and ferumoxytol.
    Mukai K; Burris NS; Mahadevan VS; Foster ED; Ordovas KG; Hope MD
    Int J Cardiovasc Imaging; 2018 Feb; 34(2):273-279. PubMed ID: 28884401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence.
    Abe Y; Yamashita Y; Namimoto T; Tang Y; Takahashi M
    Radiat Med; 2000; 18(2):97-105. PubMed ID: 10888042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage Imaging of Cerebral Aneurysms with Ferumoxytol: an Exploratory Study in an Animal Model and in Patients.
    Aoki T; Saito M; Koseki H; Tsuji K; Tsuji A; Murata K; Kasuya H; Morita A; Narumiya S; Nozaki K;
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2055-2064. PubMed ID: 28774792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved high-resolution pediatric vascular cardiovascular magnetic resonance with gadofosveset-enhanced 3D respiratory navigated, inversion recovery prepared gradient echo readout imaging compared to 3D balanced steady-state free precession readout imaging.
    Tandon A; Hashemi S; Parks WJ; Kelleman MS; Sallee D; Slesnick TC
    J Cardiovasc Magn Reson; 2016 Nov; 18(1):74. PubMed ID: 27802802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermodality feature fusion combining unenhanced computed tomography and ferumoxytol-enhanced magnetic resonance angiography for patient-specific vascular mapping in renal impairment.
    Yoshida T; Nguyen KL; Shahrouki P; Quinones-Baldrich WJ; Lawrence PF; Finn JP
    J Vasc Surg; 2020 May; 71(5):1674-1684. PubMed ID: 31734117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brand ferumoxytol vs. generic ferumoxytol comparison across two dosing regimens: a cardiac MRI image quality study.
    Dasi A; Kring DN; Selvaraj B; Morgan P; Gerity C; Morgan EE; Krishnamurthy R; Krishnamurthy R
    Pediatr Radiol; 2023 Dec; 53(13):2622-2632. PubMed ID: 37837456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive motion-compensated highly accelerated 4D flow MRI with ferumoxytol enhancement for pediatric congenital heart disease.
    Cheng JY; Hanneman K; Zhang T; Alley MT; Lai P; Tamir JI; Uecker M; Pauly JM; Lustig M; Vasanawala SS
    J Magn Reson Imaging; 2016 Jun; 43(6):1355-68. PubMed ID: 26646061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Black-blood thrombus imaging (BTI): a contrast-free cardiovascular magnetic resonance approach for the diagnosis of non-acute deep vein thrombosis.
    Xie G; Chen H; He X; Liang J; Deng W; He Z; Ye Y; Yang Q; Bi X; Liu X; Li D; Fan Z
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):4. PubMed ID: 28095878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferumoxytol-enhanced cardiovascular magnetic resonance detection of early stage acute myocarditis.
    Tada Y; Tachibana A; Heidary S; Yang PC; McConnell MV; Dash R
    J Cardiovasc Magn Reson; 2019 Dec; 21(1):77. PubMed ID: 31842900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol.
    Shahrouki P; Khan SN; Yoshida T; Iskander PJ; Ghahremani S; Finn JP
    Pediatr Radiol; 2022 Mar; 52(3):501-512. PubMed ID: 34936018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic safety and efficacy of ferumoxytol as an intravenous contrast agents in pediatric patients and young adults.
    Ning P; Zucker EJ; Wong P; Vasanawala SS
    Magn Reson Imaging; 2016 Feb; 34(2):152-8. PubMed ID: 26518061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of ferumoxytol vs gadolinium on 4D flow cardiovascular magnetic resonance measurements in small children with congenital heart disease.
    Kollar SE; Udine ML; Mandell JG; Cross RR; Loke YH; Olivieri LJ
    J Cardiovasc Magn Reson; 2022 Nov; 24(1):58. PubMed ID: 36352454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower extremity deep venous thrombosis: evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism--preliminary experience.
    Li W; Salanitri J; Tutton S; Dunkle EE; Schneider JR; Caprini JA; Pierchala LN; Jacobs PM; Edelman RR
    Radiology; 2007 Mar; 242(3):873-81. PubMed ID: 17325072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution 3D volumetric contrast-enhanced MR angiography with a blood pool agent (ferumoxytol) for diagnostic evaluation of pediatric brain arteriovenous malformations.
    Iv M; Choudhri O; Dodd RL; Vasanawala SS; Alley MT; Moseley M; Holdsworth SJ; Grant G; Cheshier S; Yeom KW
    J Neurosurg Pediatr; 2018 Sep; 22(3):251-260. PubMed ID: 29882734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced magnetic resonance venography in pediatric patients with chronic kidney disease: initial experience with ferumoxytol.
    Luhar A; Khan S; Finn JP; Ghahremani S; Griggs R; Zaritsky J; Salusky I; Hall TR
    Pediatr Radiol; 2016 Aug; 46(9):1332-40. PubMed ID: 27059620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental findings in cardiac magnetic resonance imaging: superiority of bSSFP over T1w-HASTE for extra-cardiac findings assessment.
    Sohns JM; Menke J; Schwarz A; Bergau L; Kowallick JT; Schuster A; Konietschke F; Placzek M; Weiberg D; Nordlohne S; Schmuck S; Schulz S; Derlin T; Staab W
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1581-1587. PubMed ID: 28451954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.